N-((2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(((2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

Catalog No. :
ACXXOT952
CAS No. :
97096-73-6
Molecular Formula :
C14H25NO11
Molecular Weight :
383.35

IUPAC Name:N-((2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

N-((2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(((2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(((2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide
IUPAC NameN-((2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((2R,3S,4S,5R)-2,4,5,6-tetrahydroxy-1-oxohexan-3-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide
Molecular FormulaC14H25NO11
Molecular Weight383.35
SMILESO=C[C@@H]([C@H]([C@H]([C@@H](CO)O)O)O[C@@H]1[C@H](NC(C)=O)[C@H]([C@@H]([C@@H](CO)O1)O)O)O
InChI KeyMGEICUVBTAEZNP-DEUYGTQNSA-N
Synonym3-O-(2-Acetamido-2-deoxy-a-D-glucopyranosyl)-D-galactose;3-O-(2-Acetamido-2-deoxy-α-D-glucopyranosyl)-D-galactose;D-Galactose, 3-O-[2-(acetylamino)-2-deoxy-α-D-glucopyranosyl]-
CAS No.97096-73-6

Synthetic Route by SureRoute

1. ACXXOT952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXXOT952 route product structure diagram
    ACXXOT95297096-73-6
Inquiry

2. ACXXOT952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXXOT952 route product structure diagram
    ACXXOT95297096-73-6
Inquiry

Comments (0)